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Abstract 
Melanoma of the eye is rare, but can mimic a range of disorders. This report highlights 2 
cases of choroidal melanoma with vision loss mimicking neurological diagnoses. The first 
patient is a 41-year-old white male with a known history of multiple sclerosis and a previous 
episode of optic neuritis in the right eye, who presented with a 6-month history of decreased 
vision in the same eye, and occasional photopsiae. He was treated with 2 courses of oral 
steroids for presumed recurrent optic neuritis. After a temporary improvement in his symp-
toms, his vision worsened, following which he had a head MRI, which revealed a solid intra-
ocular mass. He was subsequently diagnosed with a choroidal melanoma for which he was 
treated successfully with ruthenium-106 plaque brachytherapy. The second patient is a 57-
year-old female, who presented with a progressive cerebellar syndrome under investigation 
by the neurology service, as well as decreased vision in the right eye. Her visual acuity gradu-
ally deteriorated and her neurological assessment, which included a PET-CT, revealed uptake 
in the right eye. The diagnosis of a choroidal melanoma was made, and following conserva-
tive treatment with proton beam radiotherapy, she had an enucleation of the eye. Intraocular 
tumours can masquerade as many different entities. Unexplained unilateral visual loss, espe-
D
ow
nl
oa
de
d 
by
: 
UC
L 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
12
8.
41
.6
1.
13
 - 
4/
21
/2
01
7 
3:
04
:0
9 
PM
 Case Rep Neurol 2017;9:31–35 
DOI: 10.1159/000462970 © 2017 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/crn 
Hammamji et al.: Visual Loss from Choroidal Melanoma Mimicking Neurological 
Syndromes 
 
 
 
 
32 
cially if it is atypical for a neurological syndrome, should prompt dilated fundoscopy and 
referral to an ophthalmologist. © 2017 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Melanoma of the eye is rare, but can mimic a range of disorders. This report highlights 2 
cases of choroidal melanoma with vision loss mimicking neurological diagnoses. 
Case Reports 
We report a case series of 2 patients with neurological history and intraocular tumours. 
A 41-year-old white male with a known history of multiple sclerosis and right optic neu-
ritis presented with a 6-month history of decreased vision in the same eye, with occasional 
photopsiae. He was evaluated by a neurologist, who treated him with 2 courses of oral ster-
oids for presumed recurrent optic neuritis. After a slight temporary improvement, his vision 
worsened, following which a head MRI revealed a solid intraocular mass (Fig. 1a, b), and the 
patient was referred to our department. 
On examination, his visual acuity was 6/24 in the right eye and 6/6 in the left eye. Ante-
rior segment examination, intraocular pressures, and dilated left fundoscopy were normal. 
The right fundus showed a pigmented, elevated lesion temporal to the fovea (Fig. 1c, d). 
There was local subretinal fluid and an inferior exudative retinal detachment, as well as 
lipofuscin on the lesion. B-scan ultrasound showed a dome-shaped lesion with low internal 
reflectivity, in which the elevation was 5.7 mm and the base 12.5 mm (Fig. 1e). The diagnosis 
was compatible with a primary choroidal malignant melanoma, which was treated success-
fully with ruthenium-106 plaque brachytherapy. 
The second patient, a 57-year-old Asian female, presented to her neurologist with a pro-
gressive cerebellar syndrome and decreased vision in the right eye. Initial examination 
elsewhere revealed a visual acuity of 6/9 and a fundus appearance thought to be a retinal 
pigment epithelial detachment. Over the course of a year, her visual acuity gradually deterio-
rated to counting fingers and her neurological assessment, which included a PET-CT, re-
vealed uptake in the right eye, prompting referral to our service. 
The only ophthalmic abnormality was a 14 × 8 mm pigmented choroidal mass, abutting 
the optic nerve from 6 to 12 o’clock (Fig. 1f) in the right eye. Subretinal fluid was present. 
Ultrasound scan showed a bilobed lesion of medium-to-low echogenicity, measuring 3.4 mm 
in elevation (Fig. 1g). Again the diagnosis was primary malignant choroidal melanoma. Con-
servative treatment with proton beam radiation was attempted, but 6 months later she un-
derwent enucleation of the eye. Histopathology confirmed a primary choroidal melanoma. 
Discussion 
Although rare, choroidal melanoma is the most common primary intraocular malignant 
tumour in adults (incidence: 6 cases per million population [1]). Symptoms include blurred 
vision and photopsiae, depending on the size and location of the tumour, but can be asymp-
tomatic. The Collaborative Ocular Melanoma Study (COMS) showed a 5-year tumour-related 
mortality rate of 26–28% in large tumours, 9–11% in medium size tumours, and 1% in small 
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size tumours [2–4]. Common sites of metastases include liver (90%), lung (24%), and bone 
(16%) [5]. 
Diagnosis of choroidal melanomas is usually clinical, with fundoscopy and ancillary 
tests, including B-scan ultrasonography and in some cases fluorescein angiography. Man-
agement options include charged particle irradiation, plaque brachytherapy, local resection, 
enucleation, laser treatment, or, rarely, observation. Choice of treatment depends on multi-
ple factors including tumour size, visual acuity of the affected eye and contralateral eye, age 
and general health of the patient, and the presence of metastases [6]. 
Choroidal melanoma can masquerade other entities, such as intraocular haemorrhage, 
inflammatory granulomas, scleritis, and others [7]. In the 2 cases reported herein, there was 
an assumption that the visual symptoms were related to previous neurological diagnosis, 
particularly as undilated fundoscopy can be challenging. 
Conclusion 
Intraocular tumours can masquerade as many different entities. Unexplained unilateral 
visual loss, especially if it is atypical for a neurological syndrome, should prompt dilated 
fundoscopy and referral to an ophthalmologist. 
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Fig. 1. a Head MRI showing a solid, intraocular lesion in the right eye. b PET-CT showing uptake of the 
intraocular lesion in the right eye. c Colour fundus photograph of lightly pigmented, elevated choroidal 
lesion in the right eye. d Red-free fundus photograph of choroidal lesion in the right eye. e B-scan ultraso-
nography showing a hypoechoic lesion, measuring 3.4 mm in elevation. f Colour fundus photograph of a 
large, slightly pigmented choroidal lesion in the right eye. g B-scan ultrasonography showing a hypoechoic 
lesion, with an elevation of 5.7 mm. 
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